Literature DB >> 16240348

Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy.

Prachi Dubey1, Ali Fatemi, Hao Huang, Lidia Nagae-Poetscher, Setsu Wakana, Peter B Barker, Peter van Zijl, Hugo W Moser, Susumu Mori, Gerald V Raymond.   

Abstract

"Pure" adrenomyeloneuropathy (AMN) is the noninflammatory myeloneuropathic variant of X-linked adrenoleukodystrophy, where the disease process appears to be restricted to spinal cord tracts and peripheral nerves. The absence of obvious brain involvement makes it distinct from the inflammatory cerebral phenotypes of X-linked adrenoleukodystrophy. However, some pure AMN patients later experience development of cerebral demyelination, but little is known about the extent of brain involvement in pure AMN patients who have normal brain magnetic resonance imaging. We used diffusion tensor imaging to investigate possible occult cerebral abnormalities in such pure AMN patients. Fractional anisotropy and trace were studied in three-dimensional reconstructions of white matter tracts commonly involved in cerebral phenotypes of X-linked adrenoleukodystrophy. Results demonstrated reduced fractional anisotropy and increased trace in bilateral corticospinal tracts and genu of corpus callosum (p < 0.05). Diffusion tensor imaging-based three-dimensional fiber tracking showed occult tract-specific cerebral microstructural abnormalities in pure AMN patients who had a normal conventional brain magnetic resonance image. Corticospinal tract abnormalities could reflect a centripetal extension of spinal cord long-tract distal axonopathy. Accompanying abnormalities in genu of corpus callosum indicate that the disease pathology in pure AMN may not be limited to spinal cord long tracts alone, although the involvement of the latter is most prominent and severe.

Entities:  

Mesh:

Year:  2005        PMID: 16240348     DOI: 10.1002/ana.20643

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

Review 1.  Leukoencephalopathies and metabolic diseases.

Authors:  Antonio Giorgio; Nicola De Stefano
Journal:  Neurol Sci       Date:  2008-10       Impact factor: 3.307

Review 2.  Therapeutic strategies in adrenoleukodystrophy.

Authors:  Bela R Turk; Ann B Moser; Ali Fatemi
Journal:  Wien Med Wochenschr       Date:  2017-05-10

3.  Typical and atypical phenotype and neuroimaging of X-linked adrenoleukodystrophy in a Chinese cohort.

Authors:  Chenhui Mao; Jie Li; Xinying Huang; Jie Wang; Shanshan Chu; Yao Zhang; Liling Dong; Caiyan Liu; Lin Lu; Ling Qiu; Wei Chen; Bin Peng; Liying Cui; Jing Gao
Journal:  Neurol Sci       Date:  2022-01-08       Impact factor: 3.830

4.  Quantitative microstructural deficits in chronic phase of stroke with small volume infarcts: A diffusion tensor 3-D tractographic analysis.

Authors:  Prachi Dubey; Vasileios-Arsenios Lioutas; Rafeeque Bhadelia; Brad Manor; Peter Novak; Magdy Selim; Vera Novak
Journal:  Magn Reson Imaging       Date:  2015-12-30       Impact factor: 2.546

5.  X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.

Authors:  Marc Engelen; Stephan Kemp; Marianne de Visser; Björn M van Geel; Ronald J A Wanders; Patrick Aubourg; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2012-08-13       Impact factor: 4.123

6.  Diffusion-weighted Magnetic Resonance Imaging in the Early Diagnosis of Neonatal Adrenoleukodystrophy.

Authors:  R Nuri Sener; Mehmet H Atalar
Journal:  J Clin Imaging Sci       Date:  2011-03-31

7.  Overall intact cognitive function in male X-linked adrenoleukodystrophy adults with normal MRI.

Authors:  Noortje J M L Buermans; Sharon J G van den Bosch; Irene C Huffnagel; Marjan E Steenweg; Marc Engelen; Kim J Oostrom; Gert J Geurtsen
Journal:  Orphanet J Rare Dis       Date:  2019-09-14       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.